top of page

Fantian Zeng

Visiting Scholar

Research interest

Novel diagnostic and therapeutic strategies targeting ferroptosis for kidney diseases.

Work Experience

Liang Zhao_edited_edited.jpg

Education Background

PhD, Biochemistry and Molecular Biology, Xiamen University, 2024

MSc, Medicinal Chemistry, China Pharmaceutical University, 2020

BSc, Pharmaceutical Engineering, Fujian University of Traditional Chinese Medicinem, 2017

1. Zeng F, Nijiati S, Liu Y, Yang Q, Liu X, Zhang Q, Chen S, Su A, Xiong H, Shi C, Cai C, Lin Z, Chen X*., Zhou Z*. Ferroptosis MRI for early detection of anticancer drug-induced acute cardiac/kidney injuries. Sci Adv. 2023, 10;9(10):eadd8539.

2. Zeng F, Tang L, Zhang Q, Shi C, Huang Z, Nijiati S, Chen X*, Zhou Z*. Coordinating the Mechanisms of Action of Ferroptosis and the Photothermal Effect for Cancer Theranostics. Angew Chem Int Ed Engl. 2022, 21;61(13):e202112925. (ESI Highly Cited Paper)

3. Zeng F# , Nijiati S# , Tang L#, Ye J, Zhou Z*, Chen X*. Ferroptosis Detection: From Approaches to Applications. Angew Chem Int Ed Engl. 2023, 28;62(35):e202300379. (ESI Highly Cited Paper)

4. Zeng, F# .; Qin, Y# .; Nijiati, S.; Liu, Y.; Ye, J.; Shen, H.; Cai, J.; Xiong, H.; Shi, C.; Tang, L*.; Yu, C.*; Zhou, Z*., Ultrasmall Nanodots with Dual Anti-Ferropototic Effect for Acute Kidney Injury Therapy. Adv Sci 2024, 11 (39), e2403305.

5. Nijiati S# , Zeng F # , Zuo C, Zhang Q, Du C, Shi C, Gao J*, Zhou Z*. Fe(II)-Targeted PET/19F MRI Dual-Modal Molecular Imaging Probe for Early Evaluation of Anticancer Drug-Induced Acute Kidney Injury. Mol Pharm. 2023, 2;20(10):5185-5194.

6. Zhou, C# . Zeng, F# ; Yang, H, Liang, Z, Xu, G, Li, X*, Liu, X*, Yang, J*, Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease. Eur J Nucl Med Mol Imaging 2024, 51(10):2953-2969.

7. Shi C, Zhang Q, Yao Y, Zeng F, Du C, Nijiati S, Wen X, Zhang X, Yang H, Chen H, Guo Z, Zhang X, Gao J, Guo W, Chen X, Zhou Z. Targeting the activity of T cells by membrane  surface redox regulation for cancer theranostics. Nat Nanotechnol. 2023,18(1):86-97.

 

 

bottom of page